Code | 3691E | ||||||||||
MA number | EU/1/23/1735/001 | ||||||||||
Product Form: | con inf 1x30 ml/300 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Samsung Bioepis NL B.V., Netherland | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 26.05.2023 |
Validity: | 26.05.2028 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 02.06.2023 |